Odevixibat
( DrugBank: Odevixibat / KEGG DRUG: Odevixibat, Odevixibat hydrate )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 296 | Biliary atresia | 10 |
| 297 | Alagille syndrome | 14 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 338 | Progressive familial intrahepatic cholestasis | 4 |
296. Biliary atresia
Clinical trials : 97 / Drugs : 89 - (DrugBank : 40) / Drug target genes : 51 - Drug target pathways : 69
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
297. Alagille syndrome
Clinical trials : 48 / Drugs : 22 - (DrugBank : 6) / Drug target genes : 3 - Drug target pathways : 5
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
338. Progressive familial intrahepatic cholestasis
Clinical trials : 65 / Drugs : 27 - (DrugBank : 2) / Drug target genes : 2 - Drug target pathways : 3
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|